Intellia Therapeutics (NTLA) EBITDA Margin Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,917.00 |
| Dec 31, 2025 | 22,424.00 |
| Sep 30, 2025 | -60,690.00 |
| Jun 30, 2025 | -51,312.00 |
| Mar 31, 2025 | -5,101.00 |
| Dec 31, 2024 | -76,289.00 |
| Sep 30, 2024 | -121,881.00 |
| Jun 30, 2024 | -188,637.00 |
| Mar 31, 2024 | -16,468.00 |
| Dec 31, 2023 | 706,792.00 |
| Sep 30, 2023 | -71,029.00 |
| Jun 30, 2023 | -62,915.00 |
| Mar 31, 2023 | -49,420.00 |
| Dec 31, 2022 | -45,083.00 |
| Sep 30, 2022 | -63,517.00 |
| Jun 30, 2022 | -45,753.00 |
| Mar 31, 2022 | -114,522.00 |
| Dec 31, 2021 | -45,880.00 |
| Sep 30, 2021 | -2.38 Mn |
| Jun 30, 2021 | -88,534.00 |
| Mar 31, 2021 | -34,041.00 |
| Dec 31, 2020 | -31,588.00 |
| Sep 30, 2020 | 6,971.00 |
| Jun 30, 2020 | 4,799.00 |
| Mar 31, 2020 | -54,096.00 |